Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

192 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25-50 mg/day) versus escitalopram (10-20 mg/day) in out-patients with severe generalized anxiety disorder.
Stein DJ, Khoo JP, Ahokas A, Jarema M, Van Ameringen M, Vavrusova L, Hӧschl C, Bauer M, Bitter I, Mosolov SN, Olivier V, Matharan S, Picarel-Blanchot F, de Bodinat C. Stein DJ, et al. Among authors: bitter i. Eur Neuropsychopharmacol. 2018 Aug;28(8):970-979. doi: 10.1016/j.euroneuro.2018.05.006. Epub 2018 Jul 6. Eur Neuropsychopharmacol. 2018. PMID: 30135032 Clinical Trial.
192 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page